MxA CELL PERMEABLE MX-A RECOMBINANT PROTEIN

본 발명은 세포투과성이 증가된 MxA 재조합 단백질 및 이의 용도에 관한 것으로, 본 발명에 따른 MxA 재조합 단백질은 세포투과성이 증가되어 직접 숙주 세포 내에서 다양한 종류의 바이러스에 대한 방어 효과를 나타내므로, 이를 이용하여 다양한 바이러스에 대한 효과적인 항바이러스 제제로 사용될 수 있을 것으로 기대된다..

Medienart:

Patent

Erscheinungsjahr:

2019

Erschienen:

2019

Enthalten in:

Europäisches Patentamt - (2019) vom: 31. Dez. Zur Gesamtaufnahme - year:2019

Sprache:

Koreanisch

Links:

Volltext [kostenfrei]

Themen:

615
A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d)
Bio
C07K: Peptides (peptides containing β-lactam rings c07d;cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, c07d;ergot alkaloids of the cyclic peptide type c07d0519020000; single cell proteins, enzymes c12n;genetic engineering processes for obtaining peptides c12n0015000000)
C12N: Microorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture media (microbiological testing media c12q0001000000)
Che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2019-12-31, Last update posted on www.tib.eu: 2022-05-26, Last updated: 2023-02-09

Patentnummer:

KR102061324

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA004605152